St. Jude Progress

St. Jude research has advanced understanding of the immune response to SARS-CoV-2 infection and vaccination. Here is what the findings mean for you.

The St. Jude Case Investigation and Contact Tracing Team has been working to keep the St. Jude campus safe during the COVID-19 pandemic.

A pediatric psychologist expresses gratitude for interdisciplinary collaboration, which elevates patient care and provider well-being.

A St. Jude psychologist who provided supportive end-of-life care during the pandemic shares recommendations for making compassionate connections with patients and families.

SAFER Ukraine, a global humanitarian effort to save Ukrainian children with cancer and blood disorders began spontaneously in a digital meeting room within hours of the invasion. Existing networks fueled its growth.

What lessons can be learned from the remarkable success of SAFER Ukraine?

“SAFER Ukraine works because we have human connections with our partners,” explains Asya Agulnik, MD, MPH.

Marcin Wlodarski, MD, PhD, was new to international humanitarian work prior to volunteering with SAFER Ukraine. “I learned so much I cannot every describe it in words,” he said.

St. Jude computational biologists created a computational score predicting cancer drug sensitivity to HDAC6 inhibitors in a promising phase Ib clinical trial.

St. Jude scientists have learned that bacteria are more successful at developing antibiotic resistance when they swap genes through recombination.

Flexible and tailored implementation strategies helped pediatric cancer centers across Latin America scale up a proven quality improvement strategy.

St. Jude scientists have created the first model that faithfully recapitulates details of pediatric bone marrow failure.

St. Jude received the hospital’s first expanded access designation from the FDA for use of PET scans with [11C]Methionine a tracer that makes imaging results clearer.

The St. Jude Methodist Sickle Cell Disease Transition Clinic helps patients move from pediatric to adult care, an important stage where patients often experience roadblocks to maintaining their health.

Narrative medicines uses insight gained from listening carefully to how patients tell their own stories to improve health care, patient education and research.

May is Brain Tumor Awareness Month and a good time to learn more about the diverse group of diseases that make up the most common childhood solid tumor.

The St. Jude HPV Cancer Prevention Program and the University of Memphis created Tigers VAX Now, a student ambassador program to empower college students to advocate for HPV vaccination as cancer prevention among their peers.

Participants in the St. Jude HPV Cancer Prevention Program’s HPV Cancer Survivors School are using their powerful voices to advocate for HPV vaccination during January which is Cervical Cancer Awareness Month.

Sometimes a scientist’s next step isn’t a step, but more of a career-defining leap. Early-career investigator Lily Guenther, MD, shares her experience of taking that leap and starting a laboratory at St. Jude.

The 2022 St. Jude Global Alliance Convening brought together researchers from around the globe working to advance cures for children with catastrophic childhood diseases.

Scientists at St. Jude are leading the way on understanding cancer predisposition and the way that inherited genetics can inform patient care.

Scientists at St. Jude Children’s Research Hospital are deploying genomic technologies to hunt for vulnerabilities in cancer.

St. Jude Children’s Research Hospital has a rich history of research on genetics stemming from the Pediatric Cancer Genome Project and reverberating through laboratories today.

A St. Jude clinical trial launched more than 25 years ago has helped to transform understanding and care for children with the brain tumor craniopharyngioma.